An Intimate relationship between ROS and insulin signalling: Implications for antioxidant treatment of fatty liver disease

International Journal of Cell Biology

Volumn , Issue , 2014, Pages

  Besse Patin, Aurèle ^a,b   Estall, Jennifer L ^a,b  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; C REACTIVE PROTEIN; CATALASE; GLUTATHIONE; GLUTATHIONE PEROXIDASE 1; GLUTATHIONE TRANSFERASE; I KAPPA B KINASE BETA; INSULIN; MALONALDEHYDE; MITOGEN ACTIVATED PROTEIN KINASE 3; OXIDIZED LOW DENSITY LIPOPROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; REACTIVE OXYGEN METABOLITE; S6 KINASE; SIRTUIN 1; STRESS ACTIVATED PROTEIN KINASE 1; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THIOREDOXIN; UBIDECARENONE;

APOPTOSIS; CELL DEATH; CYTOKINE PRODUCTION; DETOXIFICATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ELECTRON TRANSPORT; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; FATTY LIVER; HALF LIFE TIME; HUMAN; HYPERGLYCEMIA; INSULIN BINDING; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; LIVER METABOLISM; LIVER MITOCHONDRION; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PHOSPHORYLATION AND DEPHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN DEGRADATION; PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

EID: 84896140767     PISSN: 16878876     EISSN: 16878884     Source Type: Journal    
DOI: 10.1155/2014/519153     Document Type: Review

References (119)

1. Hui A. Y., Wong V. W.-S., Chan H. L.-Y., Liew C.-T., Chan J. L.-Y., Chan F. K.-L., Sung J. J.-Y., Histological progression of non-alcoholic fatty liver disease in Chinese patients. Alimentary Pharmacology & Therapeutics 2005 21 4 407 413 2-s2.0-14644392822 10.1111/j.1365-2036.2005.02334.x (Pubitemid 40313943)
2. Wong V. W., Wong G. L.-H., Choi P. C.-L., Chan A. W.-H., Li M. K.-P., Chan H.-Y., Chim A. M.-L., Yu J., Sung J. J.-Y., Chan H. L.-Y., Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Gut 2010 59 7 969 974 2-s2.0-77953971188 10.1136/gut.2009.205088
3. Cohen J. C., Horton J. D., Hobbs H. H., Human fatty liver disease: old questions and new insights. Science 2011 332 6037 1519 1523 2-s2.0-79959517565 10.1126/science.1204265
4. Brunt E. M., Pathology of nonalcoholic fatty liver disease. Nature Reviews Gastroenterology & Hepatology 2010 7 4 195 203 2-s2.0-77950858243 10.1038/nrgastro.2010.21
5. Smith B. W., Adams L. A., Nonalcoholic fatty liver disease and diabetes mellitus: pathogenesis and treatment. Nature Reviews Endocrinology 2011 7 456 465 2-s2.0-79960847840 10.1038/nrendo.2011.72
6. Targher G., Day C. P., Bonora E., Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. The New England Journal of Medicine 2010 363 14 1341 1350 2-s2.0-77957375969 10.1056/NEJMra0912063
7. Schwimmer J. B., Pardee P. E., Lavine J. E., Blumkin A. K., Cook S., Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease. Circulation 2008 118 3 277 283 2-s2.0-49149114288 10.1161/CIRCULATIONAHA.107.739920
8. Kahn H. S., The lipid accumulation product is better than BMI for identifying diabetes: a population-based comparison. Diabetes Care 2006 29 1 151 153 2-s2.0-33644876260 (Pubitemid 44033451)
9. Musso G., Gambino R., Bo S., Cassader M., Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with adult treatment panel III criteria in nonobese nondiabetic subjects. Diabetes Care 2008 31 3 562 568 2-s2.0-64349123094 10.2337/dc08-0223
10. Ascha M. S., Hanouneh I. A., Lopez R., Tamimi T. A.-R., Feldstein A. F., Zein N. N., The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis. Hepatology 2010 51 6 1972 1978 2-s2.0-77952730428 10.1002/hep.23527
11. Sanyal A. J., Campbell-Sargent C., Mirshahi F., Rizzo W. B., Contos M. J., Sterling R. K., Luketic V. A., Shiffman M. L., Clore J. N., Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001 120 5 1183 1192 2-s2.0-0035084699 (Pubitemid 32246672)
12. Begriche K., Igoudjil A., Pessayre D., Fromenty B., Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 2006 6 1 1 28 2-s2.0-32844458032 10.1016/j.mito.2005.10.004 (Pubitemid 43250588)
13. Cortez-Pinto H., Chatham J., Chacko V. P., Arnold C., Rashid A., Diehl A. M., Alterations in liver ATP homeostasis in human nonalcoholic steatohepatitis: a pilot study. Journal of the American Medical Association 1999 282 17 1659 1664 2-s2.0-0033520771 10.1001/jama.282.17.1659 (Pubitemid 29513973)
14. Hensley K., Robinson K. A., Gabbita S. P., Salsman S., Floyd R. A., Reactive oxygen species, cell signaling, and cell injury. Free Radical Biology and Medicine 2000 28 10 1456 1462 2-s2.0-0034656849 10.1016/S0891-5849(00)00252- 5 (Pubitemid 30604227)
15. Perez-Carreras M., del Hoyo P., Martín M. A., Rubio J. C., Martín A., Castellano G., Colina F., Arenas J., Solis-Herruzo J. A., Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology 2003 38 4 999 1007 2-s2.0-18144444592 10.1053/jhep.2003.50398 (Pubitemid 37221683)
16. Seki S., Kitada T., Yamada T., Sakaguchi H., Nakatani K., Wakasa K., In situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver diseases. Journal of Hepatology 2002 37 1 56 62 2-s2.0-0035991444 10.1016/S0168-8278(02)00073-9 (Pubitemid 34713055)
17. Caldwell S. H., Swerdlow R. H., Khan E. M., Iezzoni J. C., Hespenheide E. E., Parks J. K., Parker W. D. Jr., Mitochondrial abnormalities in non-alcoholic steatohepatitis. Journal of Hepatology 1999 31 3 430 434 2-s2.0-0033198978 10.1016/S0168-8278(99)80033-6 (Pubitemid 29408724)
18. Vendemiale G., Grattagliano I., Caraceni P., Caraccio G., Domenicali M., Dall'Agata M., Trevisani F., Guerrieri F., Bernardi M., Altomare E., Mitochondrial oxidative injury energy metabolism alteration in rat fatty liver: effect of the nutritional status. Hepatology 2001 33 4 808 815 2-s2.0-17744370711 10.1053/jhep.2001.23060 (Pubitemid 32246628)
19. Marchesini G., Marzocchi R., Agostini F., Bugianesi E., Nonalcoholic fatty liver disease and the metabolic syndrome. Current Opinion in Lipidology 2005 16 4 421 427 10.1097/01.mol.0000174153.53683.f2 (Pubitemid 41017626)
20. Wei Y., Wang D., Topczewski F., Pagliassotti M. J., Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. American Journal of Physiology 2006 291 2 E275 E281 2-s2.0-33745828301 10.1152/ajpendo.00644.2005 (Pubitemid 44035286)
21. Ricci C., Pastukh V., Leonard J., Turrens J., Wilson G., Schaffer D., Schaffer S. W., Mitochondrial DNA damage triggers mitochondrial-superoxide generation and apoptosis. American Journal of Physiology 2008 294 2 C413 C422 2-s2.0-39349111970 10.1152/ajpcell.00362.2007 (Pubitemid 351264418)
22. Yesilova Z., Yaman H., Oktenli C., Ozcan A., Uygun A., Cakir E., Sanisoglu S. Y., Erdil A., Ates Y., Aslan M., Musabak U., Erbil M. K., Karaeren N., Dagalp K., Systemic markers of lipid peroxidation and antioxidants in patients with nonalcoholic fatty liver disease. American Journal of Gastroenterology 2005 100 4 850 855 2-s2.0-20244370723 10.1111/j.1572-0241.2005. 41500.x (Pubitemid 40592378)
23. Letteron P., Fromenty B., Terris B., Degott C., Pessayre D., Acute and chronic hepatic steatosis lead to in vivo lipid peroxidation in mice. Journal of Hepatology 1996 24 2 200 208 2-s2.0-0342716457 10.1016/S0168-8278(96)80030-4 (Pubitemid 26059117)
24. Yang S. Q., Zhu H., Li Y., Lin H., Gabrielson K., Trush M. A., Diehl A. M., Mitochondrial adaptations to obesity-related oxidant stress. Archives of Biochemistry and Biophysics 2000 378 2 259 268 2-s2.0-0034659814 10.1006/abbi.2000.1829 (Pubitemid 30397626)
25. Sumida Y., Nakashima T., Yoh T., Furutani M., Hirohama A., Kakisaka Y., Nakajima Y., Ishikawa H., Mitsuyoshi H., Okanoue T., Kashima K., Nakamura H., Yodoi J., Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease. Journal of Hepatology 2003 38 1 32 38 2-s2.0-0037232972 10.1016/S0168-8278(02)00331-8 (Pubitemid 36078521)
26. Sreekumar R., Rosado B., Rasmussen D., Charlton M., Hepatic gene expression in histologically progressive nonalcoholic steatohepatitis. Hepatology 2003 38 1 244 251 2-s2.0-0038461088 10.1053/jhep.2003.50290 (Pubitemid 36775817)
27. Leclercq I. A., Antioxidant defence mechanisms: new players in the pathogenesis of non-alcoholic steatohepatitis? Clinical Science 2004 106 3 235 237 2-s2.0-1642292288 10.1042/CS20030368 (Pubitemid 38365828)
28. Robertson G., Leclercq I., Farrell G. C., Nonalcoholic steatosis and steatohepatitis. II. Cytochrome P-450 enzymes and oxidative stress. American Journal of Physiology 2001 281 5 G1135 G1139 2-s2.0-0035196704
29. D'autreaux B., Toledano M. B., ROS as signalling molecules: mechanisms that generate specificity in ROS homeostasis. Nature Reviews Molecular Cell Biology 2007 8 10 813 824 2-s2.0-34648813720 10.1038/nrm2256 (Pubitemid 47462134)
30. Mittler R., Vanderauwera S., Suzuki N., Miller G., Tognetti V. B., Vandepoele K., Gollery M., Shulaev V., Van Breusegem F., ROS signaling: the new wave? Trends in Plant Science 2011 16 6 300 309 2-s2.0-79958042568 10.1016/j.tplants.2011.03.007
31. Ushio-Fukai M., Compartmentalization of redox signaling through NaDPH oxidase-derived rOS. Antioxidants and Redox Signaling 2009 11 6 1289 1299 2-s2.0-65349157681 10.1089/ars.2008.2333
32. Ryter S. W., Tyrrell R. M., Singlet molecular oxygen ((1)O2): a possible effector of eukaryotic gene expression. Free Radical Biology and Medicine 1998 24 9 1520 1534 2-s2.0-0031811520 10.1016/S0891-5849(97)00461-9 (Pubitemid 28270355)
33. Zuo L., Christofi F. L., Wright V. P., Bao S., Clanton T. L., Lipoxygenase-dependent superoxide release in skeletal muscle. Journal of Applied Physiology 2004 97 2 661 668 2-s2.0-3242730237 10.1152/japplphysiol.00096.2004 (Pubitemid 38963139)
34. Korshunov S. S., Skulachev V. P., Starkov A. A., High protonic potential actuates a mechanism of production of reactive oxygen species in mitochondria. FEBS Letters 1997 416 1 15 18 2-s2.0-0030729851 10.1016/S0014-5793(97)01159-9 (Pubitemid 27470791)
35. Chen K., Craige S. E., Keaney J. F., Downstream targets and intracellular compartmentalization in nox signaling. Antioxidants & Redox Signaling 2009 11 10 2467 2480 2-s2.0-70349341899
36. Turrens J. F., Mitochondrial formation of reactive oxygen species. The Journal of Physiology 2003 552 2 335 344 2-s2.0-0142150051 10.1113/jphysiol. 2003.049478 (Pubitemid 37321833)
37. Murphy M. P., How mitochondria produce reactive oxygen species. Biochemical Journal 2009 417 1 1 13 2-s2.0-58249093939 10.1042/BJ20081386
38. Skulachev V. P., Uncoupling: new approaches to an old problem of bioenergetics. Biochimica et Biophysica Acta 1998 1363 2 100 124 2-s2.0-0032564864 10.1016/S0005-2728(97)00091-1 (Pubitemid 28129344)
39. Lambert A. J., Brand M. D., Inhibitors of the quinone-binding site allow rapid superoxide production from mitochondrial NADH:ubiquinone oxidoreductase (complex I). Journal of Biological Chemistry 2004 279 38 39414 39420 2-s2.0-4544354262 10.1074/jbc.M406576200 (Pubitemid 39258206)
40. Skulachev V. P., Role of uncoupled and non-coupled oxidations in maintenance of safely low levels of oxygen and its one-electron reductants. Quarterly Reviews of Biophysics 1996 29 2 169 202 2-s2.0-0029765443 (Pubitemid 26280789)
41. Okuda M., Lee H.-C., Kumar C., Chance B., Comparison of the effect of a mitochondrial uncoupler, 2,4-dinitrophenol and adrenaline on oxygen radical production in the isolated perfused rat liver. Acta Physiologica Scandinavica 1992 145 2 159 168 2-s2.0-0026689868
42. Murphy M. P., Echtay K. S., Blaikie F. H., Asin-Cayuelat J., Cochemé H. M., Green K., Buckingham J. A., Taylort E. R., Hurrellt F., Hughes G., Miwa S., Cooper C. E., Svistunenko D. A., Smith R. A. J., Brand M. D., Superoxide activates uncoupling proteins by generating carbon-centered radicals and initiating lipid peroxidation: studies using a mitochondria- targeted spin trap derived from α -phenyl-N-tert-butylnitrone. Journal of Biological Chemistry 2003 278 49 48534 48545 2-s2.0-0346814090 10.1074/jbc.M308529200 (Pubitemid 41079491)
43. Scarpulla R. C., Metabolic control of mitochondrial biogenesis through the PGC-1 family regulatory network. Biochimica et Biophysica Acta 2011 1813 7 1269 1278 2-s2.0-79957960940 10.1016/j.bbamcr.2010.09.019
44. Rolo A. P., Gomes A. P., Palmeira C. M., Regulation of mitochondrial biogenesis in metabolic syndrome. Current Drug Targets 2011 12 6 872 878 2-s2.0-79955575803 10.2174/138945011795529056
45. Aharoni-Simon M., Hann-Obercyger M., Pen S., Madar Z., Tirosh O., Fatty liver is associated with impaired activity of PPAR γ -coactivator 1 α (PGC1 α) and mitochondrial biogenesis in mice. Laboratory Investigation 2011 91 7 1018 1028 2-s2.0-79959739128 10.1038/labinvest.2011.55
46. Wang S., Kamat A., Pergola P., Swamy A., Tio F., Cusi K., Metabolic factors in the development of hepatic steatosis and altered mitochondrial gene expression in vivo. Metabolism 2011 60 8 1090 1099 2-s2.0-79960555502 10.1016/j.metabol.2010.12.001
47. Nadal-Casellas A., Amengual-Cladera E., Proenza A. M., Lladó I., Gianotti M., Long-term high-fat-diet feeding impairs mitochondrial biogenesis in liver of male and female rats. Cellular Physiology and Biochemistry 2010 26 3 291 302 2-s2.0-78649986930 10.1159/000320552
48. Estall J. L., Ruas J. L., Choi C. S., Laznik D., Badman M., Maratos-Flier E., Shulman G. I., Spiegelman B. M., PGC-1 α negatively regulates hepatic FGF21 expression by modulating the heme/Rev-Erb α axis. Proceedings of the National Academy of Sciences of the United States of America 2009 106 52 22510 22515 2-s2.0-76049093949 10.1073/pnas.0912533106
49. Chambers K. T., Chen Z., Crawford P. A., Liver-specific PGC-1beta deficiency leads to impaired mitochondrial function and lipogenic response to fasting-refeeding. PLoS ONE 2012 7 12 e52645 10.1371/journal.pone.0052645
50. St-Pierre J., Drori S., Uldry M., Silvaggi J. M., Rhee J., Jäger S., Handschin C., Zheng K., Lin J., Yang W., Simon D. K., Bachoo R., Spiegelman B. M., Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators. Cell 2006 127 2 397 408 2-s2.0-33749999530 10.1016/j.cell.2006.09.024 (Pubitemid 44572377)
51. Kong X., Wang R., Xue Y., Liu X., Zhang H., Chen Y., Fang F., Chang Y., Sirtuin 3, a new target of PGC-1 α plays an important role in the suppression of ROS and mitochondrial biogenesis. PLoS ONE 2010 5 7 2-s2.0-77955347446 10.1371/journal.pone.0011707 e11707
52. He J., Hu B., Shi X., Activation of the aryl hydrocarbon receptor sensitizes mice to nonalcoholic steatohepatitis by deactivating mitochondrial sirtuin deacetylase Sirt3. Molecular and Cellular Biology 2013 33 10 2047 2055 10.1128/MCB.01658-12
53. Canto C., Auwerx J., PGC-1 α SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Current Opinion in Lipidology 2009 20 2 98 105 2-s2.0-64549127790 10.1097/MOL.0b013e328328d0a4
54. Deng X. Q., Chen L. L., Li N. X., The expression of SIRT1 in nonalcoholic fatty liver disease induced by high-fat diet in rats. Liver International 2007 27 5 708 715 2-s2.0-34547101692 10.1111/j.1478-3231.2007.01497.x (Pubitemid 47097323)
55. Wang R. H., Kim H.-S., Xiao C., Xu X., Gavrilova O., Deng C.-X., Hepatic Sirt1 deficiency in mice impairs mTorc2/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance. The Journal of Clinical Investigation 2011 121 11 4477 4490 2-s2.0-80555146753 10.1172/JCI46243
56. Serviddio G., Bellanti F., Sastre J., Vendemiale G., Altomare E., Targeting mitochondria: a new promising approach for the treatment of liver diseases. Current Medicinal Chemistry 2010 17 22 2325 2337 2-s2.0-77955650026 10.2174/092986710791698530
57. Houstis N., Rosen E. D., Lander E. S., Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006 440 7086 944 948 2-s2.0-33645860825 10.1038/nature04634
58. 2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. The Journal of Clinical Investigation 2009 119 3 573 581 2-s2.0-67650815430 10.1172/JCI37048
59. Szeto H. H., Mitochondria-targeted cytoprotective peptides for ischemia-reperfusion injury. Antioxidants & Redox Signaling 2008 10 3 601 619 2-s2.0-38349010993 10.1089/ars.2007.1892
60. Zhao K., Zhao G.-M., Wu D., Soong Y., Birk A. V., Schiller P. W., Szeto H. H., Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. Journal of Biological Chemistry 2004 279 33 34682 34690 2-s2.0-4544370680 10.1074/jbc.M402999200 (Pubitemid 39318098)
61. Nakamura S., Takamura T., Matsuzawa-Nagata N., Takayama H., Misu H., Noda H., Nabemoto S., Kurita S., Ota T., Ando H., Miyamoto K.-I., Kaneko S., Palmitate induces insulin resistance in H4IIEC3 hepatocytes through reactive oxygen species produced by mitochondria. Journal of Biological Chemistry 2009 284 22 14809 14818 2-s2.0-67649304876 10.1074/jbc.M901488200
62. 2 by overexpressing peroxiredoxin 3 improves glucose tolerance in mice. Aging Cell 2008 7 6 866 878 2-s2.0-56849124393 10.1111/j.1474-9726.2008.00432.x (Pubitemid 352749440)
63. Lee H. Y., Choi C. S., Birkenfeld A. L., Alves T. C., Jornayvaz F. R., Jurczak M. J., Zhang D., Woo D. K., Shadel G. S., Ladiges W., Rabinovitch P. S., Santos J. H., Petersen K. F., Samuel V. T., Shulman G. I., Targeted expression of catalase to mitochondria prevents age-associated reductions in mitochondrial function and insulin resistance. Cell Metabolism 2010 12 6 668 674 2-s2.0-78649497300 10.1016/j.cmet.2010.11.004
64. Holloszy J. O., 'Deficiency' of mitochondria in muscle does not cause insulin resistance. Diabetes 2013 62 4 1036 1040 10.2337/db12-1107
65. O'neill E. D., Wilding J. P. H., Kahn C. R., Van Remmen H., McArdle A., Jackson M. J., Close G. L., Absence of insulin signalling in skeletal muscle is associated with reduced muscle mass and function: evidence for decreased protein synthesis and not increased degradation. Age 2010 32 2 209 222 2-s2.0-77953027226 10.1007/s11357-009-9125-0
66. Matsuzawa-Nagata N., Takamura T., Ando H., Nakamura S., Kurita S., Misu H., Ota T., Yokoyama M., Honda M., Miyamoto K.-I., Kaneko S., Increased oxidative stress precedes the onset of high-fat diet-induced insulin resistance and obesity. Metabolism 2008 57 8 1071 1077 2-s2.0-47149115165 10.1016/j.metabol.2008.03.010 (Pubitemid 351978066)
67. Bonnard C., Durand A., Peyrol S., Chanseaume E., Chauvin M.-A., Morio B., Vidal H., Rieusset J., Mitochondrial dysfunction results from oxidative stress in the skeletal muscle of diet-induced insulin-resistant mice. The Journal of Clinical Investigation 2008 118 2 789 800 2-s2.0-38849199866 10.1172/JCI32601 (Pubitemid 351206566)
68. Barazzoni R., Zanetti M., Cappellari G. G., Semolic A., Boschelle M., Codarin E., Pirulli A., Cattin L., Guarnieri G., Fatty acids acutely enhance insulin-induced oxidative stress and cause insulin resistance by increasing mitochondrial reactive oxygen species (ROS) generation and nuclear factor- B inhibitor (I B)-nuclear factor- B (NF B) activation in rat muscle, in the absence of mitochondrial dysfunction. Diabetologia 2012 55 3 773 782 2-s2.0-84856730254 10.1007/s00125-011-2396-x
69. Merry T. L., Tran M., Stathopoulos M., High fat fed obese Gpx1-deficient mice exhibit defective insulin secretion but protection from hepatic steatosis and liver damage. Antioxidants & Redox Signaling 2013 10.1089/ars.2013.5428
70. Forman H. J., Reactive oxygen species and α β -unsaturated aldehydes as second messengers in signal transduction. Annals of the New York Academy of Sciences 2010 1203 35 44 2-s2.0-77956234404 10.1111/j.1749-6632.2010. 05551.x
71. Jones D. P., Radical-free biology of oxidative stress. American Journal of Physiology 2008 295 4 C849 C868 2-s2.0-55149107716 10.1152/ajpcell.00283.2008
72. Chiarugi P., PTPs versus PTKs: the redox side of the coin. Free Radical Research 2005 39 4 353 364 2-s2.0-18144383207 10.1080/10715760400027987 (Pubitemid 40613714)
73. Tonks N. K., Redox redux: revisiting PTPs and the control of cell signaling. Cell 2005 121 5 667 670 2-s2.0-20444400257 10.1016/j.cell.2005.05.016 (Pubitemid 40797589)
74. Foley T. D., Petro L. A., Stredny C. M., Coppa T. M., Oxidative inhibition of protein phosphatase 2A activity: role of catalytic subunit disulfides. Neurochemical Research 2007 32 11 1957 1964 2-s2.0-34848914455 10.1007/s11064-007-9394-x (Pubitemid 47497899)
75. Wright V. P., Reiser P. J., Clanton T. L., Redox modulation of global phosphatase activity and protein phosphorylation in intact skeletal muscle. The Journal of Physiology 2009 587 23 5767 5781 2-s2.0-71249163851 10.1113/jphysiol.2009.178285
76. Barford D., Das A. K., Egloff M. P., The structure and mechanism of protein phosphatases: insights into catalysis and regulation. Annual Review of Biophysics and Biomolecular Structure 1998 27 133 164 2-s2.0-0031860103 10.1146/annurev.biophys.27.1.133 (Pubitemid 28286012)
77. Fetrow J. S., Siew N., Skolnick J., Structure-based functional motif identifies a potential disulfide oxidoreductase active site in the serine/threonine protein phosphatase-1 subfamily. FASEB Journal 1999 13 13 1866 1874 2-s2.0-0032843737 (Pubitemid 29473350)
78. Maher P., Redox control of neural function: background, mechanisms, and significance. Antioxidants & Redox Signaling 2006 8 11-12 1941 1970 2-s2.0-33947612587 (Pubitemid 46489624)
79. Dasgupta J., Kar S., Liu R., Joseph J., Kalyanaraman B., Remington S. J., Chen C., Melendez J. A., Reactive oxygen species control senescence-associated matrix metalloproteinase-1 through c-Jun-N-terminal kinase. Journal of Cellular Physiology 2010 225 1 52 62 2-s2.0-77956555183 10.1002/jcp.22193
80. Covey T. M., Edes K., Coombs G. S., Virshup D. M., Fitzpatrick F. A., Alkylation of the tumor suppressor PTEN activates Akt and β -catenin signaling: a mechanism linking inflammation and oxidative stress with cancer. PLoS ONE 2010 5 10 2-s2.0-78149448121 10.1371/journal.pone.0013545 e13545
81. Lu G., Ren S., Korge P., Choi J., Dong Y., Weiss J., Koehler C., Chen J.-N., Wang Y., A novel mitochondrial matrix serine/threonine protein phosphatase regulates the mitochondria permeability transition pore and is essential for cellular survival and development. Genes and Development 2007 21 7 784 796 2-s2.0-34147129534 10.1101/gad.1499107 (Pubitemid 46572358)
82. Bashan N., Kovsan J., Kachko I., Ovadia H., Rudich A., Positive and negative regulation of insulin signaling by reactive oxygen and nitrogen species. Physiological Reviews 2009 89 1 27 71 2-s2.0-58249110569 10.1152/physrev.00014.2008
83. Goldstein B. J., Mahadev K., Wu X., Zhu L., Motoshima H., Role of insulin-induced reactive oxygen species in the insulin signaling pathway. Antioxidants & Redox Signaling 2005 7 7-8 1021 1031 2-s2.0-17644399404 10.1089/ars.2005.7.1021 (Pubitemid 40973798)
84. Iwakami S., Misu H., Takeda T., Sugimori M., Matsugo S., Kaneko S., Takamura T., Concentration-dependent dual effects of hydrogen peroxide on insulin signal transduction in H4IIEC hepatocytes. PLoS ONE 2011 6 11 2-s2.0-81055140936 10.1371/journal.pone.0027401 e27401
85. 2 and plays an integral role in insulin signal transduction. Molecular and Cellular Biology 2004 24 5 1844 1854 2-s2.0-1342304048 10.1128/MCB.24.5.1844-1854.2004 (Pubitemid 38248927)
86. Li Y., Mouche S., Sajic T., Veyrat-Durebex C., Supale R., Pierroz D., Ferrari S., Negro F., Hasler U., Feraille E., Moll S., Meda P., Deffert C., Montet X., Krause K.-H., Szanto I., Deficiency in the NADPH oxidase 4 predisposes towards diet-induced obesity. International Journal of Obesity 2012 36 1 1503 1513 2-s2.0-84858304324 10.1038/ijo.2011.279
87. Fiaschi T., Buricchi F., Cozzi G., Matthias S., Parri M., Raugei G., Ramponi G., Chiarugi P., Redox-dependent and ligand-independent trans-activation of insulin receptor by globular adiponectin. Hepatology 2007 46 1 130 139 2-s2.0-34547403216 10.1002/hep.21643 (Pubitemid 47171929)
88. 2 accumulation for cell signaling. Cell 2010 140 4 517 528 2-s2.0-76749102420 10.1016/j.cell.2010.01.009
89. Boura-Halfon S., Zick Y., Phosphorylation of IRS proteins, insulin action, and insulin resistance. American Journal of Physiology 2009 296 4 E581 E591 2-s2.0-65649098029 10.1152/ajpendo.90437.2008
90. Hirosumi J., Tuncman G., Chang L., Görgün C. Z., Uysal K. T., Maeda K., Karin M., Hotamisligil G. S., A central, role for JNK in obesity and insulin resistance. Nature 2002 420 6913 333 336 2-s2.0-0037153158 10.1038/nature01137 (Pubitemid 35398190)
91. Bost F., Aouadi M., Caron L., Even P., Belmonte N., Prot M., Dani C., Hofman P., Pagès G., Pouysségur J., Le Marchand-Brustel Y., Binétruy B., The extracellular signal-regulated kinase isoform ERK1 is specifically required for in vitro and in vivo adipogenesis. Diabetes 2005 54 2 402 411 2-s2.0-19944433322 10.2337/diabetes.54.2.402
92. Sung H. U., Frigerio F., Watanabe M., Picard F., Joaquin M., Sticker M., Fumagalli S., Allegrini P. R., Kozma S. C., Auwerx J., Thomas G., Absence of S6K1 protects against age- and diet-induced obesity while enhancing insulin sensitivity. Nature 2004 431 7005 200 205. Erratum in Nature, vol. 431, no. 7007, p. 485, 2004 2-s2.0-19544394606 10.1038/nature02979 (Pubitemid 39329591)
93. Yuan M., Konstantopoulos N., Lee J., Hansen L., Li Z.-W., Karin M., Shoelson S. E., Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikk β Science 2001 293 5535 1673 1677 2-s2.0-0035979775 10.1126/science.1061620 (Pubitemid 32807849)
94. Xiao F., Huang Z., Li H., Yu J., Wang C., Chen S., Meng Q., Cheng Y., Gao X., Li J., Liu Y., Guo F., Leucine deprivation increases hepatic insulin sensitivity via GCN2/mTOR/S6K1 and AMPK pathways. Diabetes 2011 60 3 746 756 2-s2.0-79952374033 10.2337/db10-1246
95. Jiang S., Messina J. L., Role of inhibitory B kinase and c-Jun NH2-terminal kinase in the development of hepatic insulin resistance in critical illness diabetes. American Journal of Physiology 2011 301 3 G454 G463 2-s2.0-80052294383 10.1152/ajpgi.00148.2011
96. Wang Y., Shi M., Fu H., Xu H., Wei J., Wang T., Wang X., Mammalian target of the rapamycin pathway is involved in non-alcoholic fatty liver disease. Molecular Medicine Reports 2010 3 6 909 915 2-s2.0-78649473370 10.3892/mmr.2010.365
97. Xi L., Xiao C., Bandsma R. H. J., Naples M., Adeli K., Lewis G. F., C-reactive protein impairs hepatic insulin sensitivity and insulin signaling in rats: role of mitogen-activated protein kinases. Hepatology 2011 53 1 127 135 2-s2.0-78751494753 10.1002/hep.24011
98. Mumby M. C., Walter G., Protein serine/threonine phosphatases: structure, regulation, and functions in cell growth. Physiological Reviews 1993 73 4 673 699 2-s2.0-0027143725 (Pubitemid 24004649)
99. Shearn C. T., Reigan P., Petersen D. R., Inhibition of hydrogen peroxide signaling by 4-hydroxynonenal due to differential regulation of Akt1 and Akt2 contributes to decreases in cell survival and proliferation in hepatocellular carcinoma cells. Free Radical Biology and Medicine 2012 53 1 1 11 10.1016/j.freeradbiomed.2012.04.021
100. Hahn K., Miranda M., Francis V. A., Vendrell J., Zorzano A., Teleman A. A., PP2A regulatory subunit PP2A-B′ counteracts S6K phosphorylation. Cell Metabolism 2010 11 5 438 444 2-s2.0-77955285637 10.1016/j.cmet.2010.03.015
101. Loukili N., Rosenblatt-Velin N., Rolli J., Levrand S., Feihl F., Waeber B., Pacher P., Liaudet L., Oxidants positively or negatively regulate nuclear factor B in a context-dependent manner. Journal of Biological Chemistry 2010 285 21 15746 15752 2-s2.0-77952355889 10.1074/jbc.M110.103259
102. Szypowska A. A., Burgering B. M. T., The peroxide dilemma: opposing and mediating insulin action. Antioxidants & Redox Signaling 2011 15 1 219 232 2-s2.0-79958203720 10.1089/ars.2010.3794
103. Tanti J. F., Jager J., Cellular mechanisms of insulin resistance: role of stress-regulated serine kinases and insulin receptor substrates (IRS) serine phosphorylation. Current Opinion in Pharmacology 2009 9 6 753 762 2-s2.0-70449724835 10.1016/j.coph.2009.07.004
104. Matsuzawa A., Ichijo H., Redox control of cell fate by MAP kinase: physiological roles of ASK1-MAP kinase pathway in stress signaling. Biochimica et Biophysica Acta 2008 1780 11 1325 1336 2-s2.0-49349083531 10.1016/j.bbagen.2007.12.011
105. Gao D., Nong S., Huang X., Lu Y., Zhao H., Lin Y., Man Y., Wang S., Yang J., Li J., The effects of palmitate on hepatic insulin resistance are mediated by NADPH oxidase 3-derived reactive oxygen species through JNK and p38 MAPK pathways. Journal of Biological Chemistry 2010 285 39 29965 29973 2-s2.0-77956921023 10.1074/jbc.M110.128694
106. Corcoran A., Cotter T. G., Redox regulation of protein kinases. The FEBS Journal 2013 280 9 1944 1965 10.1111/febs.12224
107. Khan N., Swartz H., Measurements in vivo of parameters pertinent to ROS/RNS using EPR spectroscopy. Molecular and Cellular Biochemistry 2002 234-235 1 341 357 2-s2.0-4243897255 10.1023/A:1015938528432 (Pubitemid 34784576)
108. Drougard A., Duparc T., Brenachot X., Hypothalamic apelin/reactive oxygen species signaling controls hepatic glucose metabolism in the onset of diabetes. Antioxidants & Redox Signaling 2013 20 4 557 573 10.1089/ars.2013.5182
109. Lu Y. Y., Chen T.-S., Wang X.-P., Li L., Single-cell analysis of dihydroartemisinin-induced apoptosis through reactive oxygen species-mediated caspase-8 activation and mitochondrial pathway in ASTC-a-1 cells using fluorescence imaging techniques. Journal of Biomedical Optics 2010 15 4 2-s2.0-79952197787 10.1117/1.3481141 046028
110. Valle A., Catalán V., Rodríguez A., Rotellar F., Valentí V., Silva C., Salvador J., Frühbeck G., Gómez-Ambrosi J., Roca P., Oliver J., Identification of liver proteins altered by type 2 diabetes mellitus in obese subjects. Liver International 2012 32 6 951 961 2-s2.0-84857129604 10.1111/j.1478-3231.2012.02765.x
111. D'alessandro A., Rinalducci S., Zolla L., Redox proteomics and drug development. Journal of Proteomics 2011 74 12 2575 2595 2-s2.0-81055130176 10.1016/j.jprot.2011.01.001
112. Shearn C. T., Fritz K. S., Reigan P., Petersen D. R., Modification of Akt2 by 4-hydroxynonenal inhibits insulin-dependent Akt signaling in HepG2 cells. Biochemistry 2011 50 19 3984 3996 2-s2.0-79955830382 10.1021/bi200029w
113. Lindemann C., Leichert L. I., Quantitative redox proteomics: the NOxICAT method. Quantitative Methods in Proteomics 2012 893 387 403 Methods in Molecular Biology 10.1007/978-1-61779-885-6-24
114. Baumgardner J. N., Shankar K., Hennings L., Albano E., Badger T. M., Ronis M. J. J., N-acetylcysteine attenuates progression of liver pathology in a rat model of nonalcoholic steatohepatitis. The Journal of Nutrition 2008 138 10 1872 1879 2-s2.0-54749129969
115. Chen H., Karne R. J., Hall G., Campia U., Panza J. A., Cannon R. O. III, Wang Y., Katz A., Levine M., Quon M. J., High-dose oral vitamin C partially replenishes vitamin C levels in patients with type 2 diabetes and low vitamin C levels but does not improve endothelial dysfunction or insulin resistance. American Journal of Physiology 2006 290 1 H137 H145 2-s2.0-33644807156 10.1152/ajpheart.00768.2005
116. Liu S., Lee I.-M., Song Y., Van Denburgh M., Cook N. R., Manson J. E., Buring J. E., Vitamin E and risk of type 2 diabetes in the women's health study randomized controlled trial. Diabetes 2006 55 10 2856 2862 2-s2.0-33750889377 10.2337/db06-0456 (Pubitemid 44923687)
117. Dufour J. F., Oneta C. M., Gonvers J.-J., Bihl F., Cerny A., Cereda J.-M., Zala J.-F., Helbling B., Steuerwald M., Zimmermann A., Randomized placebo-controlled trial of ursodeoxycholic acid with vitamin E in nonalcoholic steatohepatitis. Clinical Gastroenterology and Hepatology 2006 4 12 1537 1543 2-s2.0-33845336554 10.1016/j.cgh.2006.09.025 (Pubitemid 44880031)
118. Mercer J. R., Yu E., Figg N., Cheng K.-K., Prime T. A., Griffin J. L., Masoodi M., Vidal-Puig A., Murphy M. P., Bennett M. R., The mitochondria- targeted antioxidant MitoQ decreases features of the metabolic syndrome in ATM+/-/ApoE-/- mice. Free Radical Biology and Medicine 2012 52 5 841 849 2-s2.0-84856752588 10.1016/j.freeradbiomed.2011.11.026
119. Smith R. A., Murphy M. P., Animal and human studies with the mitochondria-targeted antioxidant MitoQ. Annals of the New York Academy of Sciences 2010 1201 96 103 2-s2.0-77955283395 10.1111/j.1749-6632.2010.05627.x